SEC Tracker
Get the app
EDVA · XBRL financial data

Endovia Health Sciences financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (EDVA's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024†Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025†Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue5,1442,688*1,5411,047982586*4380*0*(365)*40*
Cost of revenue3,8471,955*1,377802691930*4690*0*———
Gross profit1,297733*164244291(344)*(30)0*0*—2—
Selling, general and administrative3,049———————————
General and administrative————55———————
Total operating expenses5,6204,020*3,4143,9352,9616,092*2,0021,6339,5451,024*9812,007
Other operating income (expense)—————year only———year only——
Operating income (loss)(4,324)(3,287)*(3,250)(3,691)(2,670)(6,435)*(2,033)(1,633)(9,545)(976)*(979)(2,007)
Interest income01*0110*——————
Interest expense2211,296*5336228901,657*637625320941*889231
Other income (expense)(1,347)(2,707)*(1)(1,636)(2,050)(2,604)*(1,618)(6,860)(341)(1,343)*—245
Income tax expense (benefit)00*0000*0000*00
Net income (loss)(5,670)(5,994)*(4,671)(5,327)(4,720)(9,039)*(3,650)(8,493)(9,886)(3,205)*(2,136)(2,055)
Earnings per share, basic USD per share(0.13)(0.13)*————(1.97)———(0.47)—
Earnings per share, diluted USD per share(0.13)(0.13)*————(1.97)———(0.47)—
Weighted average shares, basic thousands of shares42,81247,424*44,79449,1165,273—1,8571,9002,192—4,5683,065
Weighted average shares, diluted thousands of shares42,81247,424*44,79449,1165,273—1,8571,9002,192—4,5683,065
  • † Share count changed about 1/32 in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 4x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal quarters (EDVA's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024†Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025†Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents9638015845715—17266281381243
Accounts receivable1,513891756669595397173141140162014
Inventory2,9072,2521,4721,3061,341893861855855345555
Total current assets5,1193,9772,8362,5383,0401,9041,6951,6051,971632709900
Property and equipment, net386350313274242205168131941311—
Right-of-use asset6205564924273613512772021264833—
Goodwill257257257257257———————
Total assets11,2449,8998,5588,0588,3642,7592,50922,23722,4899667701,076
Accounts payable4,1994,4444,9454,9245,5805,2326,3247,0436,7464,8104,6314,091
Total current liabilities11,13014,75017,02316,82017,78119,36920,41813,44615,64216,26016,97216,825
Lease liability, non-current36329622815989543720123——
Total liabilities11,90215,50418,06118,41219,19221,39422,53713,51915,71216,26716,97316,825
Accumulated deficit(127,341)(133,335)(136,747)(142,073)(146,793)(155,832)(159,483)(167,992)(178,284)(181,899)(184,412)(186,828)
Total stockholders' equity(658)(5,605)(9,503)(10,354)(10,828)(18,635)(20,028)8,7186,778(15,301)(16,203)(15,749)
Total liabilities and equity11,2449,8998,5588,0588,3642,7592,50922,23722,4899667701,076
Common shares outstanding (cover page) thousands of shares43,81845,13047,65657,46861,7111,9001,8922,1432,5519,95410,9656,413
  • † Share count changed about 1/32 in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 4x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal quarters (EDVA's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024†Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025†Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(5,670)(5,994)*(4,671)(5,327)(4,720)(9,039)*(3,650)(8,493)(9,886)(3,205)*(2,136)(2,055)
Stock-based compensation367(54)*5571,342187271*141547,752677*1771,108
Net cash from operating activities(1,982)*(1,685)*(1,308)(2,430)*(2,645)*(1,620)*(724)(680)*(2,424)*(991)*(930)(1,092)*
Net cash from investing activities0*(2)*02*(5)*0*——————
Proceeds from issuing common stock0*0*————————1,400—
Proceeds from issuing equity————————149*500*1,3721,577*
Net cash from financing activities1,145*1,979*9502,422*3,014*1,159*756696*2,674*978*1,0541,156*
Net change in cash(807)*284*(365)(6)*449*(442)*(15)17*248*17*100(138)*
  • † Share count changed about 1/32 in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 4x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 2080 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 2080 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Endovia Health Sciences2430*(1,092)*6.4M0.2 quarters 10-QJun 30, 2026
Heritage Distilling Holding Company19736(1,644)*995,9330.0 quarters 10-QJun 30, 2026
SRX Global35,1863,392not reported20.3M— 10-QJun 30, 2026
LQR House145346(1,554)*1.3M4.7 quarters 10-QJun 30, 2026
EQUATOR Beverage01,511not reported9.6M— 10-QSep 30, 2026
Reed's2,4107,488(2,170)*11.9M1.1 quarters 10-QJun 30, 2026
Willamette Valley Vineyards59010,0361,950*5.0M— 10-QJun 30, 2026
Jones Soda2,35110,168(2,007)*125.9M1.2 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.